Mr Jose Morgado
Hospital Juan Ramon Jimenez, Huelva (Spain)
Can we expect results in addition to the paradigm and provide trial with use of Sacubitril/Valsartan in a real life cohort?
Event: Heart Failure 2021
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: ePoster session
Laboratory value-based innovation in heart failure can improve patient health-related outcomes
Event: Heart Failure 2021
Topic: Biomarkers
Session: ePoster session
Is it possible the use of sacubitril/valsartan in HFrEF and hemodialysis?
Event: Heart Failure 2018
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
It is possible to avoid an ICD implantation with empagliflozine?
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Chronic heart failure
Session: Clinical Case Corner 3 - Metabolic issues in heart failure: don't forget periphery!
Use of ISGLT-2 in Diabetes Mellitus type 2 and heart failure
Event: EuroPrevent 2017
Topic: Diabetes
Session: Diabetes/ Lipids/Obesity/Nutrition_Part 1
ESC 365 is supported by
